I've highlighted 3 important lines to follow on AVCO's chart above.
At close on Monday, AVCO was trading above its 50-Day Simple Moving Average (SMA) and its 13-Day Exponential Moving Average.
Now, if it is able to clear through resistance at its 200-Day SMA in the near term, it could provide a breakout spark towards a potential squeeze.
These 3 lines will be vital to watch closely this week.
-----
No. 2 AVCO Potential Catalyst - Low Float Could Allow For Daily Volatility (+ Explosive Chart History)
According to the Yahoo Finance website, AVCO has a low float.
The website reports this profile to have approximately 37.78Mn shares in its float.
Why is that important? It's important on one crucial level. Volatility.
Could more positive company news before the end of the year help provide a near term spark?
On top of that, take another look at AVCO's chart above and check out its explosive potential.
Multiple times over the past few months we've seen explosive, short term moves.
-----
No. 3 AVCO Potential Catalyst - Company Receives Notice Of Allowance Related To QTY Protein Platform
Avalon GloboCare Receives Allowance for Joint U.S. Patent
Jointly with MIT, the Company also Submitted a New U.S. Patent Application for QTY Glucose Transporters
FREEHOLD, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today provided an update regarding the Company’s intellectual property portfolio featuring its QTY protein code technology.
...
Read the full article here.
-----
No. 4 AVCO Potential Catalyst - New Publication In Top-Ranked Journal Is Turning Heads
Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society
FREEHOLD, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced a new publication featuring the Company’s QTY protein code technology in Chemical Reviews, a top-ranked peer-reviewed scientific journal and the official journal of American Chemical Society (journal Impact Factor is 72). The publication, entitled “Protein Design: From the Aspect of Water Solubility and Stability,” focuses on the innovative QTY protein design code—co-developed by Avalon—as a novel platform to generate water-soluble proteins for a wide spectrum of biomedical applications. The Company initially licensed the technology from the Massachusetts Institute of Technology (MIT) and has advanced the platform through a sponsored research agreement with the university.
...
Read the full article here.
-----
No. 5 AVCO Potential Catalyst - A Game-Changing New Study Featuring AI Enhanced Protein Design "QTY Code" Tech
Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer
FREEHOLD, N.J., June 30, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced a new study applying artificial intelligence (AI) enhanced protein design “QTY Code” technology. The method is expected to accelerate development of therapeutic monoclonal antibodies to treat cancer.
...
Read the full article here.
-----
AVCO Recap: These Potential Catalysts Could Fuel A Vertical Move For This Nasdaq Profile
No. 1 - Could A Squeeze Be Nearing As AVCO Approaches Its 200-Day SMA?
No. 2 - Low Float Could Allow For Daily Volatility (+ Explosive Chart History)
No. 3 - Company Receives Notice Of Allowance Related To QTY Protein Platform
No. 4 - New Publication In Top-Ranked Journal Is Turning Heads
No. 5 - A Game-Changing New Study Featuring AI Enhanced Protein Design "QTY Code" Tech
-----
Coverage is officially reinitiated on AVCO. When time permits, do this:
